Last reviewed · How we verify

NCT05151393

Correlation Between Serum Vitamin D3 and Incidence of Uterine Leiomyoma

Status unknown Last updated 9 December 2021
What this trial tests

trial testing Measuring vitamin D3 level in Vitamin D Deficiency in 80 participants. Status unknown.

Timeline
1 December 2021
Primary endpoint
28 January 2022
15 February 2022

Quick facts

Lead sponsorAin Shams University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment80
Start date1 December 2021
Primary completion28 January 2022
Estimated completion15 February 2022

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 20 to 45, female only, with Vitamin D Deficiency or Leiomyoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the current study is to evaluate the association between low serum vitamin D level and incidence of uterine leiomyoma in Egyptian women as the research hypothesis that low serum vitamin D is considered a risk factor for uterine leiomyoma

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Vitamin D Deficiency

Currently open trials in the same condition.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05151393.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing